Heart drug trial offers new hope for slowing advanced breast cancer
NCT ID NCT02958852
Summary
This study tested if adding atorvastatin, a common cholesterol-lowering drug, to standard hormone therapy could better control advanced breast cancer. It involved 126 women with hormone-sensitive, advanced breast cancer to see if the combination delayed cancer growth longer than hormone therapy alone. The trial also aimed to understand why some cancers stop responding to hormone treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lund University Hospital, Department of Oncology
Lund, 221 85, Sweden
Conditions
Explore the condition pages connected to this study.